Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Association studies of up to 1.2 million individuals yield new insights into the genetic etiology of tobacco and alcohol use

Abstract

Tobacco and alcohol use are leading causes of mortality that influence risk for many complex diseases and disorders1. They are heritable2,3 and etiologically related4,5 behaviors that have been resistant to gene discovery efforts6,7,8,9,10,11. In sample sizes up to 1.2 million individuals, we discovered 566 genetic variants in 406 loci associated with multiple stages of tobacco use (initiation, cessation, and heaviness) as well as alcohol use, with 150 loci evidencing pleiotropic association. Smoking phenotypes were positively genetically correlated with many health conditions, whereas alcohol use was negatively correlated with these conditions, such that increased genetic risk for alcohol use is associated with lower disease risk. We report evidence for the involvement of many systems in tobacco and alcohol use, including genes involved in nicotinic, dopaminergic, and glutamatergic neurotransmission. The results provide a solid starting point to evaluate the effects of these loci in model organisms and more precise substance use measures.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Genetic correlations between substance use phenotypes and phenotypes from other large GWAS.
Fig. 2: Pleiotropy.
Fig. 3: Heritability and polygenic prediction.
Fig. 4: Correlations among exemplary DEPICT gene sets.

Similar content being viewed by others

Code availability

All software used to perform these analyses is available online.

Data availability

GWAS summary statistics can be downloaded online (https://genome.psych.umn.edu/index.php/GSCAN). We provide association results for all SNPs that passed quality-control filters in a GWAS meta-analysis of each of our five substance use phenotypes that excludes the research participants from 23andMe.

References

  1. Ezzati, M. et al. Selected major risk factors and global and regional burden of disease. Lancet 360, 1347–1360 (2002).

    Article  PubMed  Google Scholar 

  2. Hicks, B. M., Schalet, B. D., Malone, S. M., Iacono, W. G. & McGue, M. Psychometric and genetic architecture of substance use disorder and behavioral disinhibition measures for gene association studies. Behav. Genet. 41, 459–475 (2011).

    Article  PubMed  Google Scholar 

  3. Polderman, T. J. et al. Meta-analysis of the heritability of human traits based on fifty years of twin studies. Nat. Genet. 47, 702–709 (2015).

    Article  CAS  PubMed  Google Scholar 

  4. Kendler, K. S., Schmitt, E., Aggen, S. H. & Prescott, C. A. Genetic and environmental influences on alcohol, caffeine, cannabis, and nicotine use from early adolescence to middle adulthood. Arch. Gen. Psychiatry 65, 674–682 (2008).

    Article  PubMed  PubMed Central  Google Scholar 

  5. Kendler, K. S., Prescott, C. A., Myers, J. & Neale, M. C. The structure of genetic and environmental risk factors for common psychiatric and substance use disorders in men and women. Arch. Gen. Psychiatry 60, 929–937 (2003).

    Article  PubMed  Google Scholar 

  6. Bierut, L. J. et al. ADH1B is associated with alcohol dependence and alcohol consumption in populations of European and African ancestry. Mol. Psychiatry 17, 445–450 (2012).

    Article  CAS  PubMed  Google Scholar 

  7. Thorgeirsson, T. E. et al. Sequence variants at CHRNB3CHRNA6 and CYP2A6 affect smoking behavior. Nat. Genet. 42, 448–453 (2010).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Thorgeirsson, T. E. et al. A rare missense mutation in CHRNA4 associates with smoking behavior and its consequences. Mol. Psychiatry 21, 594–600 (2016).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Furberg, H. et al. Genome-wide meta-analyses identify multiple loci associated with smoking behavior. Nat. Genet. 42, 441–447 (2010).

    Article  CAS  Google Scholar 

  10. Schumann, G. et al. KLB is associated with alcohol drinking, and its gene product β-Klotho is necessary for FGF21 regulation of alcohol preference. Proc. Natl Acad. Sci. USA 113, 14372–14377 (2016).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Jorgenson, E. et al. Genetic contributors to variation in alcohol consumption vary by race/ethnicity in a large multi-ethnic genome-wide association study. Mol. Psychiatry 22, 1359–1367 (2017).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Polesskaya, O. O., Smith, R. F. & Fryxell, K. J. Chronic nicotine doses down-regulate PDE4 isoforms that are targets of antidepressants in adolescent female rats. Biol. Psychiatry 61, 56–64 (2007).

    Article  CAS  PubMed  Google Scholar 

  13. Boyden, L. M. et al. Mutations in kelch-like 3 and cullin 3 cause hypertension and electrolyte abnormalities. Nature 482, 98–102 (2012).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Wang, W. et al. Forced expiratory volume in the first second and aldosterone as mediators of smoking effect on stroke in African Americans: the Jackson Heart Study. J. Am. Heart Assoc. 5, e002689 (2016).

  15. Aoun, E. G. et al. A relationship between the aldosterone-mineralocorticoid receptor pathway and alcohol drinking: preliminary translational findings across rats, monkeys and humans. Mol. Psychiatry 23, 1466–1473 (2018).

    Article  CAS  PubMed  Google Scholar 

  16. Turley, P. et al. Multi-trait analysis of genome-wide association summary statistics using MTAG. Nat. Genet. 50, 229–237 (2018).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Bulik-Sullivan, B. K. et al. LD score regression distinguishes confounding from polygenicity in genome-wide association studies. Nat. Genet. 47, 291–295 (2015).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Yang, J. A., Lee, S. H., Goddard, M. E. & Visscher, P. M. GCTA: a tool for genome-wide complex trait analysis. Am. J. Hum. Genet. 88, 76–82 (2011).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Zheng, J. et al. LD Hub: a centralized database and web interface to perform LD score regression that maximizes the potential of summary level GWAS data for SNP heritability and genetic correlation analysis. Bioinformatics 33, 272–279 (2017).

    Article  CAS  PubMed  Google Scholar 

  20. Harris, K. M., Halpern, C. T., Haberstick, B. C. & Smolen, A. The National Longitudinal Study of Adolescent Health (Add Health) sibling pairs data. Twin Res. Hum. Genet. 16, 391–398 (2013).

    Article  PubMed  Google Scholar 

  21. Sonnega, A. et al. Cohort profile: the Health and Retirement Study (HRS). Int. J. Epidemiol. 43, 576–585 (2014).

    Article  PubMed  PubMed Central  Google Scholar 

  22. Finucane, H. K. et al. Partitioning heritability by functional annotation using genome-wide association summary statistics. Nat. Genet. 47, 1228–1235 (2015).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Wilson, S., Bair, J. L., Thomas, K. M. & Iacono, W. G. Problematic alcohol use and reduced hippocampal volume: a meta-analytic review. Psychol. Med. 47, 2288–2301 (2017).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Ewing, S. W. F., Sakhardande, A. & Blakemore, S. J. The effect of alcohol consumption on the adolescent brain: a systematic review of MRI and fMRI studies of alcohol-using youth. Neuroimage Clin. 5, 420–437 (2014).

    Article  PubMed  Google Scholar 

  25. Goldstein, R. Z. & Volkow, N. D. Dysfunction of the prefrontal cortex in addiction: neuroimaging findings and clinical implications. Nat. Rev. Neurosci. 12, 652–669 (2011).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Volkow, N. D. & Morales, M. The brain on drugs: from reward to addiction. Cell 162, 712–725 (2015).

    Article  CAS  PubMed  Google Scholar 

  27. Koob, G. F. & Volkow, N. D. Neurocircuitry of addiction. Neuropsychopharmacology 35, 217–238 (2010).

    Article  PubMed  Google Scholar 

  28. Koob, G. F. & Volkow, N. D. Neurobiology of addiction: a neurocircuitry analysis. Lancet Psychiatry 3, 760–773 (2016).

    Article  PubMed  PubMed Central  Google Scholar 

  29. Fernandez, E., Schiappa, R., Girault, J. A. & Le Novere, N. DARPP-32 is a robust integrator of dopamine and glutamate signals. PLoS Comput. Biol. 2, 1619–1633 (2006).

    Article  CAS  Google Scholar 

  30. Yagishita, S. et al. A critical time window for dopamine actions on the structural plasticity of dendritic spines. Science 345, 1616–1620 (2014).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Zhu, H. W. et al. DARPP-32 phosphorylation opposes the behavioral effects of nicotine. Biol. Psychiatry 58, 981–989 (2005).

    Article  CAS  PubMed  Google Scholar 

  32. Stoker, A. K. & Markou, A. Unraveling the neurobiology of nicotine dependence using genetically engineered mice. Curr. Opin. Neurobiol. 23, 493–499 (2013).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Litten, R. Z. et al. A double-blind, placebo-controlled trial assessing the efficacy of varenicline tartrate for alcohol dependence. J. Addiction Med. 7, 277–286 (2013).

    Article  CAS  Google Scholar 

  34. Hyman, S. E., Malenka, R. C. & Nestler, E. J. Neural mechanisms of addiction: the role of reward-related learning and memory. Annu. Rev. Neurosci. 29, 565–598 (2006).

    Article  CAS  PubMed  Google Scholar 

  35. Kalivas, P. W. The glutamate homeostasis hypothesis of addiction. Nat. Rev. Neurosci. 10, 561–572 (2009).

    Article  CAS  PubMed  Google Scholar 

  36. Szumlinski, K. K. et al. Methamphetamine addiction vulnerability: the glutamate, the bad, and the ugly. Biol. Psychiatry 81, 959–970 (2017).

    Article  CAS  PubMed  Google Scholar 

  37. Gass, J. T. & Olive, M. F. Glutamatergic substrates of drug addiction and alcoholism. Biochem. Pharmacol. 75, 218–265 (2008).

    Article  CAS  PubMed  Google Scholar 

  38. Vaughan, J. et al. Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor. Nature 378, 287–292 (1995).

    Article  CAS  PubMed  Google Scholar 

  39. Logrip, M. L., Koob, G. F. & Zorrilla, E. P. Role of corticotropin-releasing factor in drug addiction: potential for pharmacological intervention. CNS Drugs 25, 271–287 (2011).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Volkow, N. D., Koob, G. F. & McLellan, A. T. Neurobiologic advances from the brain disease model of addiction. N. Engl. J. Med. 374, 363–371 (2016).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. McCarthy, S. et al. A reference panel of 64,976 haplotypes for genotype imputation. Nat. Genet. 48, 1279–1283 (2016).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Lassi, G. et al. The CHRNA5A3B4 gene cluster and smoking: from discovery to therapeutics. Trends Neurosci. 39, 851–861 (2016).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Edenberg, H. J. The genetics of alcohol metabolism: role of alcohol dehydrogenase and aldehyde dehydrogenase variants. Alcohol Res. Health 30, 5–13 (2007).

    PubMed  PubMed Central  Google Scholar 

  44. Sallese, M. et al. The G-protein-coupled receptor kinase GRK4 mediates homologous desensitization of metabotropic glutamate receptor 1. FASEB J. 14, 2569–2580 (2000).

    Article  CAS  PubMed  Google Scholar 

  45. Perroy, J., Adam, L., Qanbar, R., Chenier, S. & Bouvier, M. Phosphorylation-independent desensitization of GABAB receptor by GRK4. EMBO J. 22, 3816–3824 (2003).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Yang, J., Villar, V. M., Armando, I., Jose, P. A. & Zeng, C. Y. G. G protein–coupled receptor kinases: crucial regulators of blood pressure. J. Am. Heart Assoc. 5, e003519 (2016).

    PubMed  PubMed Central  Google Scholar 

  47. GTEx Consortium et al. Genetic effects on gene expression across human tissues. Nature 550, 204–213 (2017). erratum 553, 530 (2018).

  48. Costas, J. The highly pleiotropic gene SLC39A8 as an opportunity to gain insight into the molecular pathogenesis of schizophrenia. Am. J. Med. Genet. B Neuropsychiatr. Genet. 177, 274–283 (2018).

    Article  CAS  PubMed  Google Scholar 

  49. Kong, A. et al. The nature of nurture: effects of parental genotypes. Science 359, 424–428 (2018).

    Article  CAS  PubMed  Google Scholar 

  50. Vrieze, S. I., Hicks, B. M., Iacono, W. G. & McGue, M. Decline in genetic influence on the co-occurrence of alcohol, marijuana, and nicotine dependence symptoms from age 14 to 29. Am. J. Psychiatry 169, 1073–1081 (2012).

    Article  PubMed  PubMed Central  Google Scholar 

  51. Das, S. et al. Next-generation genotype imputation service and methods. Nat. Genet. 48, 1284–1287 (2016).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  52. Howie, B., Fuchsberger, C., Stephens, M., Marchini, J. & Abecasis, G. R. Fast and accurate genotype imputation in genome-wide association studies through pre-phasing. Nat. Genet. 44, 955–959 (2012).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  53. Zhan, X., Hu, Y., Li, B., Abecasis, G. R. & Liu, D. J. RVTESTS: an efficient and comprehensive tool for rare variant association analysis using sequence data. Bioinformatics 32, 1423–1426 (2016).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  54. Kang, H. M. et al. Variance component model to account for sample structure in genome-wide association studies. Nat. Genet. 42, 348–354 (2010).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  55. Price, A. L. et al. Principal components analysis corrects for stratification in genome-wide association studies. Nat. Genet. 38, 904–909 (2006).

    Article  CAS  PubMed  Google Scholar 

  56. Devlin, B. & Roeder, K. Genomic control for association studies. Biometrics 55, 997–1004 (1999).

    Article  CAS  PubMed  Google Scholar 

  57. Jiang, Y. et al. Proper conditional analysis in the presence of missing data identified novel independently associated low frequency variants in nicotine dependence genes. PLoS Genet. 14, e1007452 (2018).

  58. Yang, J. et al. Conditional and joint multiple-SNP analysis of GWAS summary statistics identifies additional variants influencing complex traits. Nat. Genet. 44, S1–S3 (2012).

    Article  CAS  Google Scholar 

  59. Grotzinger, A. D. et al. Genomic sem provides insights into the multivariate genetic architecture of complex traits. Preprint at https://doi.org/10.1101/305029 (2018).

  60. Li, J. & Ji, L. Adjusting multiple testing in multilocus analyses using the eigenvalues of a correlation matrix. Heredity 95, 221–227 (2005).

    Article  CAS  PubMed  Google Scholar 

  61. Gao, X. Y., Becker, L. C., Becker, D. M., Starmer, J. D. & Province, M. A. Avoiding the high Bonferroni penalty in genome-wide association studies. Genet. Epidemiol. 34, 100–105 (2010).

    PubMed  PubMed Central  Google Scholar 

  62. Chen, Z. X. & Liu, Q. Z. a new approach to account for the correlations among single nucleotide polymorphisms in genome-wide association studies. Hum. Hered. 72, 1–9 (2011).

    Article  PubMed  PubMed Central  Google Scholar 

  63. Chang, C. C. et al. Second-generation PLINK: rising to the challenge of larger and richer datasets. Gigascience 4, 7 (2015).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  64. Wu, Y., Zheng, Z. L., Visscher, P. M. & Yang, J. Quantifying the mapping precision of genome-wide association studies using whole-genome sequencing data. Genome Biol. 18, 86 (2017).

    Article  PubMed  PubMed Central  Google Scholar 

  65. Bulik-Sullivan, B. et al. An atlas of genetic correlations across human diseases and traits. Nat. Genet. 47, 1236–1241 (2015).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  66. Vilhjalmsson, B. J. et al. Modeling linkage disequilibrium increases accuracy of polygenic risk scores. Am. J. Hum. Genet. 97, 576–592 (2015).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  67. Li, Y., Davila-Velderrain, J. & Kellis, M. A probabilistic framework to dissect functional cell-type-specific regulatory elements and risk loci underlying the genetics of complex traits. Preprint at https://doi.org/10.1101/059345 (2017).

  68. Zhan, X. & Liu, D. J. SEQMINER: an R-package to facilitate the functional interpretation of sequence-based associations. Genet. Epidemiol. 39, 619–623 (2015).

    Article  PubMed  PubMed Central  Google Scholar 

  69. Lamparter, D., Marbach, D., Rueedi, R., Kutalik, Z. & Bergmann, S. Fast and rigorous computation of gene and pathway scores from SNP-based summary statistics. PLoS Comput. Biol. 12, e1004714 (2016).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  70. Pers, T. H. et al. Biological interpretation of genome-wide association studies using predicted gene functions. Nat. Commun. 6, 5890 (2015).

    Article  CAS  PubMed  Google Scholar 

  71. Frey, B. J. & Dueck, D. Clustering by passing messages between data points. Science 315, 972–976 (2007).

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This study was designed and carried out by the GWAS and Sequencing Consortium of Alcohol and Nicotine use (GSCAN). It was conducted by using the UK Biobank Resource under application number 16651. This study was supported by funding from US National Institutes of Health awards R01DA037904 to S.V., R01HG008983 to D. J. Liu., and R21DA040177 to D. J. Liu. Ethical review and approval was provided by the University of Minnesota institutional review board; all human subjects provided informed consent. A full list of acknowledgements is provided in the Supplementary Note.

23andMe Research Team

Michelle Agee11, Babak Alipanahi11, Adam Auton11, Robert K. Bell11, Katarzyna Bryc11, Sarah L. Elson11, Pierre Fontanillas11, Nicholas A. Furlotte11, David A. Hinds11, Bethann S. Hromatka11, Karen E. Huber11, Aaron Kleinman11, Nadia K. Litterman11, Matthew H. McIntyre11, Joanna L. Mountain11, Carrie A.M. Northover11, J. Fah Sathirapongsasuti11, Olga V. Sazonova11, Janie F. Shelton11, Suyash Shringarpure11, Chao Tian11, Joyce Y. Tung11, Vladimir Vacic11, Catherine H. Wilson11 and Steven J. Pitts11.

HUNT All-In Psychiatry

Amy Mitchell65, Anne Heidi Skogholt20, Bendik S Winsvold65,78, Børge Sivertsen79,80,81, Eystein Stordal80,82, Gunnar Morken80,83, Håvard Kallestad80,83, Ingrid Heuch81, John-Anker Zwart65,78,84, Katrine Kveli Fjukstad85,86, Linda M Pedersen65, Maiken Elvestad Gabrielsen20, Marianne Bakke Johnsen65,84, Marit Skrove87, Marit Sæbø Indredavik80,87, Ole Kristian Drange80,83, Ottar Bjerkeset80,88, Sigrid Børte65,84 and Synne Øien Stensland65,89

Author information

Authors and Affiliations

Authors

Consortia

Contributions

G.A., D.J.L., and S.V. designed the study. D.J.L. and S.V. led and oversaw the study. M. Liu was the study’s lead analyst. She was assisted by Y.J., D.J.L., S.V., R.W., D.M.B., and G.D. Bonferroni thresholds were calculated by D.M. Phenotype definitions were developed by L.J.B., M.C.C., D.A.H., J.K., E.J., D.J.L., M.M., M.R.M., S.V., and L.Z. Software development was carried out by Y.J., D.J.L., and X.Z. Conditional analyses were performed by Y.J. and M. Liu. Heritability, genetic correlation, and polygenic scoring analyses were performed by R.W. Multivariate analyses were performed by Y.J., M. Liu, and D.J.L. Bioinformatics analyses were performed and interpreted by F. Chen, J.D., J.J.L., Y. Li, M. Liu, J. A. Stitzel, S.V., and R.W. The LocusZoom website was designed by G.D. Figures were created by M. Liu, R.W., Y. Li, and S.V. M.A.E. and M.C.K. helped with data access. R.W. coordinated authorship and acknowledgement details. M.C.C., S.P.D., E.J., J.K., and J. A. Stitzel provided helpful advice and feedback on study design and the manuscript. All authors contributed to and critically reviewed the manuscript. Y. Li, D.J.L., M. Liu, S.V., and R.W. made major contributions to the writing and editing.

Corresponding authors

Correspondence to Dajiang J. Liu or Scott Vrieze.

Ethics declarations

Competing interests

L.J.B. and the spouse of N.L.S. are listed as inventors on issued US patent number 8,080,371, ‘Markers for Addiction’, covering the use of certain SNPs in determining the diagnosis, prognosis, and treatment of addiction. S.P.D. is a scientific advisor to BaseHealth, Inc. G.B., D.F.G., G.W.R., H.S., K.S., and T.E.T. are employees of deCODE Genetics/Amgen, Inc. C.T. and D.H. are employees of 23andMe, Inc.

Additional information

Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Supplementary Text and Figures

Supplementary Figures 1–18 and Supplementary Note

Reporting Summary

Supplementary Tables

Supplementary Tables 1–31

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Liu, M., Jiang, Y., Wedow, R. et al. Association studies of up to 1.2 million individuals yield new insights into the genetic etiology of tobacco and alcohol use. Nat Genet 51, 237–244 (2019). https://doi.org/10.1038/s41588-018-0307-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41588-018-0307-5

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing